168 related articles for article (PubMed ID: 24856851)
1. Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach.
Bradish JR; Cheng L
Hum Pathol; 2014 Jul; 45(7):1315-26. PubMed ID: 24856851
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
Held L; Eigentler TK; Metzler G; Leiter U; Messina JL; Glass LF; Garbe C; Bauer J
Am J Pathol; 2013 Mar; 182(3):640-5. PubMed ID: 23261261
[TBL] [Abstract][Full Text] [Related]
3. Molecular testing in malignant melanoma.
Grossmann AH; Grossmann KF; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis.
Bastian BC
Pathology; 2004 Oct; 36(5):458-61. PubMed ID: 15370116
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.
Blokx WA; van Dijk MC; Ruiter DJ
Histopathology; 2010 Jan; 56(1):121-32. PubMed ID: 20055910
[TBL] [Abstract][Full Text] [Related]
8. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
Martinez SR; Hoon DS
J Cell Biochem; 2005 Oct; 96(3):473-83. PubMed ID: 16088931
[TBL] [Abstract][Full Text] [Related]
10. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
11. Ras, Raf, and MAP kinase in melanoma.
Solus JF; Kraft S
Adv Anat Pathol; 2013 Jul; 20(4):217-26. PubMed ID: 23752084
[TBL] [Abstract][Full Text] [Related]
12. Update in molecular diagnostics in melanocytic neoplasms.
Cooper C; Sorrell J; Gerami P
Adv Anat Pathol; 2012 Nov; 19(6):410-6. PubMed ID: 23060066
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
15. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients.
Scolyer RA; Prieto VG
Surg Oncol Clin N Am; 2011 Jan; 20(1):19-37. PubMed ID: 21111957
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
17. Main clues in the pathologic diagnosis of melanoma: is molecular genetics helping?
Ferrara G; Senetta R; Paglierani M; Massi D
Dermatol Ther; 2012; 25(5):423-31. PubMed ID: 23046021
[TBL] [Abstract][Full Text] [Related]
18. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
19. [Molecular testing in malignant melanoma].
Dundr P; Staněk L; Němejcová K; Jakša R
Cesk Patol; 2014 Jul; 50(3):127-31. PubMed ID: 25186593
[TBL] [Abstract][Full Text] [Related]
20. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]